BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11073267)

  • 1. Molecular mechanisms of secondary hyperparathyroidism.
    Silver J
    Nephrol Dial Transplant; 2000; 15 Suppl 5():2-7. PubMed ID: 11073267
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of secondary hyperparathyroidism.
    Silver J; Kilav R; Naveh-Many T
    Am J Physiol Renal Physiol; 2002 Sep; 283(3):F367-76. PubMed ID: 12167586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperparathyroidism and renal failure.
    Arnaud CD
    Kidney Int; 1973 Aug; 4(2):89-95. PubMed ID: 4598144
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular and molecular mechanisms of secondary hyperparathyroidism.
    Silver J; Levi R
    Clin Nephrol; 2005 Feb; 63(2):119-26. PubMed ID: 15730054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary hyperparathyroidism].
    Nakanishi S; Fukagawa M
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():341-6. PubMed ID: 16279659
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of hemodialysis on secondary hyperparathyroidism in patients with chronic renal failure.
    Johnson JW; Hattner RS; Hampers CL; Bernstein DS; Merrill JP; Sherwood LM
    Metabolism; 1972 Jan; 21(1):18-29. PubMed ID: 5008012
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of parathyroid hormone synthesis in chronic renal failure in rats.
    Fukagawa M; Kaname S; Igarashi T; Ogata E; Kurokawa K
    Kidney Int; 1991 May; 39(5):874-81. PubMed ID: 2067203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro.
    Almaden Y; Hernandez A; Torregrosa V; Canalejo A; Sabate L; Fernandez Cruz L; Campistol JM; Torres A; Rodriguez M
    J Am Soc Nephrol; 1998 Oct; 9(10):1845-52. PubMed ID: 9773785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dialysis bone disease associated with secondary hyperparathyroidism].
    Nakazawa R
    Nihon Rinsho; 1992 Jan; 50 Suppl():783-8. PubMed ID: 1578767
    [No Abstract]   [Full Text] [Related]  

  • 10. Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation.
    Wallfelt CH; Larsson R; Gylfe E; Ljunghall S; Rastad J; Akerström G
    World J Surg; 1988 Aug; 12(4):431-8. PubMed ID: 3420928
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of parathyroid function in chronic renal failure.
    Rodriguez M; Cañadillas S; Lopez I; Aguilera-Tejero E; Almaden Y
    J Bone Miner Metab; 2006; 24(2):164-8. PubMed ID: 16502126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure.
    Slatopolsky E; Dusso A; Brown AJ
    Am J Med Sci; 1999 Jun; 317(6):370-6. PubMed ID: 10372836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of calcium-sensing receptor abnormality in the pathogenesis of secondary hyperparathyroidism.
    Akizawa T; Ogata H; Koiwa F; Kinugasa E; Ideura T
    Nephrol Dial Transplant; 1999; 14 Suppl 1():66-7. PubMed ID: 10048456
    [No Abstract]   [Full Text] [Related]  

  • 14. Extraosseous calcification in patients with chronic renal failure--no escape?
    Braun J
    Nephrol Dial Transplant; 2005 Oct; 20(10):2054-9. PubMed ID: 16077145
    [No Abstract]   [Full Text] [Related]  

  • 15. Skeletal resistance to the calcaemic action of parathyroid hormone in uraemia: a mechanism for the hypocalcaemia and secondary hyperparathyroidism of chronic renal failure.
    Massry SG
    Clin Endocrinol (Oxf); 1976; 5 Suppl():317S-325S. PubMed ID: 1052781
    [No Abstract]   [Full Text] [Related]  

  • 16. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
    Lafage-Proust MH
    Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of increased parathyroid hormone mRNA in experimental uremia: roles of protein RNA binding and RNA degradation.
    Yalcindag C; Silver J; Naveh-Many T
    J Am Soc Nephrol; 1999 Dec; 10(12):2562-8. PubMed ID: 10589695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal osteodystrophy and vitamin D derivatives: cellular mechanisms of hyperparathyroidism in uremia.
    Fukagawa M; Kurokawa K
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():96-9. PubMed ID: 1338454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
    Korkor AB
    N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell proliferation of parathyroid gland in patients with progressive secondary hyperparathyroidism: Vitamin D receptor, calcium sensing receptor, and cell cycle regulation factor].
    Tokumoto M; Taniguchi M; Matsuo D; Tsuruya K; Hirakata H; Iida M
    Clin Calcium; 2005 Sep; 15 Suppl 1():206-16. PubMed ID: 16279026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.